Buying Cannabis At-Taif

__________________________

📍 Verified store!

📍 Guarantees! Quality! Reviews!

__________________________

▼▼ ▼▼ ▼▼ ▼▼ ▼▼ ▼▼ ▼▼

▲▲ ▲▲ ▲▲ ▲▲ ▲▲ ▲▲ ▲▲

Buying Cannabis At-Taif

Taif Rose Honey is a rare and exquisite honey harvested from the famous mountainous rose gardens of Taif in the provence of Makkah, often referred to as the City of Roses, Taif is known for the famously fragrant flowers that grow in the surrounding wadis and mountains. It's also known as Saudi's unofficial summer capital. Because of its altitude, Taif is a cool escape from the heat and is regarded as one of the best honey varieties in the Middle East. Every spring, the city of Taif blooms pink and red. First, the rose bushes blossom in the valley of Wadi Mahram, then higher up in Al Hada, and finally at 2, meters in Al Shafa, the mountains to the south of the city. The highly priced oil extracted from these roses is famous in the Muslim world and is favoured by the royals of the Middle East along with major brands such as Givenchy and Jimmy Choo to name a few. The unique rose taste, colour, and scent combine to make this an extraordinary honey that is completely natural, nothing is infused, just the bees feeding from the beautiful roses and collecting the abundance of nectar and producing this prized variety. Due to this honey being another rare find and small-batch, we have made a few jars available exclusively, get yours before they have sold out! This rose honey is an excellent spread that pairs well with hearty freshly-baked bread, we recommend taking this honey on its own to benefit from the full flavour and associated health benefits. Not sure about the taste? Why not purchase our beautiful 45g mini jar to sample the taste! I ordered the taster pot of this - wish I had got large one It is smooth, velvety and has a fragrant taste of rose. Absolutely delicious- will definitely order the full sized next time. It is my first time to buy such a lovely product and definitely not the last. It is healthy and genuine honey. I have never tasted any honey like this. It costs a premium but what luxury it is! Beautiful rose flavour that lingers in your mouth delicious. Wow, what an absolutely amazing honey. A delicious taste of rose, such a delicate yet tasty honey which improves on the palette. The more I have, the more I want. Shop See more 'Close Cart'. Currency See more Currency 'Close Cart'. View in your space. A Stunning Natural Honey From Taif Makkah Taif Rose Honey is a rare and exquisite honey harvested from the famous mountainous rose gardens of Taif in the provence of Makkah, often referred to as the City of Roses, Taif is known for the famously fragrant flowers that grow in the surrounding wadis and mountains. Uses This rose honey is an excellent spread that pairs well with hearty freshly-baked bread, we recommend taking this honey on its own to benefit from the full flavour and associated health benefits. Produce of Saudi Arabia. Shipping calculated at checkout. Add to Cart. Customer Reviews.

Pure Taif Rose Honey

Buying Cannabis At-Taif

Federal government websites often end in. Before sharing sensitive information, make sure you're on a federal government site. The site is secure. NCBI Bookshelf. Sukhdeep Bains ; Taif Mukhdomi. Authors Sukhdeep Bains 1 ; Taif Mukhdomi. Over the past few years, medicinal cannabis has increasingly become a topic of conversation regarding its role in treating chronic pain. Medicinal cannabis is not an FDA-approved medication, although a licensed practitioner can prescribe it. This activity highlights the mechanism of action, indications, contraindications, and pertinent clinical studies regarding the possible role of cannabis in the treatment of chronic pain and the importance of an interprofessional approach for the treatment of chronic pain. Objectives: Assess the history of medicinal cannabis use. Identify the mechanism of action of medicinal cannabis. Evaluate the role of cannabis in the treatment of different types of chronic pain. Access free multiple choice questions on this topic. Chronic pain is a growing widespread health concern across the United States. Therefore, treatment of chronic pain also requires a multifaceted approach, including pharmacological, non-pharmacological, and interventional measures. In light of the recent opioid epidemic, medicinal cannabis has gained traction as a possible treatment for chronic pain. As more states legalize the use of medical marijuana, healthcare professionals must understand the mechanism of action, indications, contraindications, role, and controversy of medicinal marijuana in treating chronic pain. Cannabis consists of many compounds, most of which are 60 pharmacologically active cannabinoids that act upon endogenous cannabinoid receptors in the body. THC contributes to the psychoactive effects of marijuana, including euphoria and psychosis. On the other hand, CBD is not psychoactive and is considered to have anti-anxiety and anti-psychoactive properties. Recreational cannabis tends to contain a higher concentration of THC, whereas medicinal cannabis contains a higher concentration of CBD to limit the psychoactive effects of the drug. There are 2 primary types of endocannabinoid receptors: cannabinoid receptors type 1 CB1 and cannabinoid receptors type 2 CB2. Both receptors are classified as G-protein coupled receptors. CB1 receptors are located in the central and peripheral nervous system, specifically in the centers of the brain involved in pain modulation, the nociceptive pathways of the spinal cord, and peripheral nerves. THC is a partial agonist at both CB1 and CB2 receptors and inhibits the release of glutamate, 5-hydroxytryptamine and alters dopaminergic function, thereby affecting pain pathways. Due to the increasing support for the use of medicinal cannabis, it is essential to understand the federal and state policies related to the legalization of marijuana. As of , a total of 36 states have legalized marijuana for medical purposes. Accessibility to medicinal cannabis for chronic pain patients varies as different states regulate the number of dispensaries and restrict the proximities of dispensaries within each state. Although medical marijuana is legal in more than half of the United States and is considered a possible treatment for chronic pain, it is still classified as a Schedule 1 drug. As with any other medication, there are several adverse effects associated with medicinal cannabis. Acute adverse effects related to THC include anxiety, panic, disorientation, impaired attention, short-term memory, and driving performance. Hence, it is prudent to avoid medicinal cannabis in patients with psychiatric illnesses, such as schizophrenia, as it may exacerbate the condition. Additionally, CBD has potential drug interactions with conventional pharmacotherapies as it interacts with cytochrome P CYP enzymes involved in drug metabolism. The use of medical marijuana can be traced back to over years ago. It was used by early Chinese physicians to treat pain associated with childbirth, rheumatic pain, malaria, and even constipation. The first state to legalize the use of marijuana under the supervision of a physician was California in under the provision of the Compassionate Use Act. One particular study evaluated chronic pain patients' perspectives on medical marijuana. The study included chronic pain patients, including those with neuropathic pain, back pain, arthritis, post-surgical pain, headaches, and abdominal pain. In this particular study, two-thirds of patients reported pain relief as the main benefit of marijuana use. Improved sleep was the second most commonly reported benefit. On the other hand, the primary negative theme amongst these patients was the cost associated with medicinal cannabis. Unlike other medications, medicinal cannabis is not covered by insurance companies, leading to increased costs. Other negative themes associated with medicinal cannabis use amongst these patients were adverse effects of the medication and perceived bias against marijuana use. Due to the ongoing opioid epidemic, medicinal cannabis as a possible alternative treatment has become increasingly important. Unlike opioids, marijuana does not cause respiratory depression, leading to lower mortality rates. A different study highlighted the effectiveness of medical marijuana in treating chronic non-cancer pain, neuropathic pain, medication-rebound headaches, and allodynia. However, it did not appear to have the same effectiveness as non-opioid analgesics for the treatment of acute pain. Furthermore, in this particular study, medicinal cannabis was no more effective than a placebo for treating visceral pain and only provided minimal analgesic effect in cancer pain. There have also been a few randomized controlled trials studying the dosing and administration of medicinal cannabis. In 1 specific study, experts across 9 different countries developed 3 different treatment protocols for the dosing and administration of cannabis when treating patients with chronic pain. In the routine treatment protocol, it was agreed that a 5-milligram CBD-predominant strain of cannabis taken twice daily should be the initiating form of treatment due to its safety profile. If greater than or equal to 40 milligrams of CBD per day failed to provide adequate pain relief, a starting dose of 2. As per the consensus, THC could be slowly titrated up to 2. Expert consultation from a cannabinoid specialist or experienced medicinal cannabis clinical was recommended if the dosing, as mentioned above, failed to provide adequate pain relief. In the conservative treatment protocol, the initiating CBD dose was 5 milligrams once or twice daily up to a maximum of 40 milligrams, followed by an initiating dose of 1 milligram of THC if the maximum CBD-predominant dose provided inadequate pain control. The THC dose could then be titrated up by 1 milligram every 7 days to reach a maximum dosage of 40 milligrams daily. The initial starting dose was 2. The dosage could be titrated up by 2. Many of the studies that have been performed analyzing the potential benefit of medicinal cannabis in treating chronic pain have small sample sizes. Marijuana's status as a Schedule 1 substance certainly contributes to the lack of ample data. However, as more states pass legislation legalizing marijuana, more studies with larger sample sizes will ensue. Cannabis use continues to be a politically charged topic. Regulations among states vary, contributing to the difficulty in prescribing medicinal cannabis to patients suffering from chronic pain. Although preliminary data has supported the use of medicinal cannabis in the treatment of chronic pain, it is quite evident that further research needs to be performed to fully determine its true role in the world of pain management. The interest in exploring alternative treatments for chronic pain spurred by the opioid epidemic has created an opportunity to find treatments outside of the norm, from cannabis to even psychedelics. The treatment of chronic pain requires an interprofessional approach. As with any patient encounter, a thorough history and physical exam are essential when delineating appropriate treatment options for chronic pain patients. The complexity of treating chronic pain patients is attributable to the subjective nature of pain, the variability of pain tolerance amongst patients, and the psychosocial impact of chronic pain. Therefore, effective collaboration among various disciplines, including physiatrists, physical therapists, psychologists, pain management physicians, neurologists, psychiatrists, and social workers, is necessary to ensure the best possible outcome for patients. Questionnaires and other forms can be offered to patients to monitor symptomatic improvement in pain and quality of life after initiating cannabis use. Nonetheless, ongoing research and studies are required to determine the actual effectiveness of medicinal cannabis as a possible alternative treatment for chronic pain. Disclosure: Sukhdeep Bains declares no relevant financial relationships with ineligible companies. Disclosure: Taif Mukhdomi declares no relevant financial relationships with ineligible companies. You are not required to obtain permission to distribute this article, provided that you credit the author and journal. Turn recording back on. Help Accessibility Careers. StatPearls \[Internet\]. Search term. Affiliations 1 Nassau University Medical Center. Continuing Education Activity Over the past few years, medicinal cannabis has increasingly become a topic of conversation regarding its role in treating chronic pain. Introduction Chronic pain is a growing widespread health concern across the United States. Function Cannabis consists of many compounds, most of which are 60 pharmacologically active cannabinoids that act upon endogenous cannabinoid receptors in the body. Issues of Concern Due to the increasing support for the use of medicinal cannabis, it is essential to understand the federal and state policies related to the legalization of marijuana. Clinical Significance The use of medical marijuana can be traced back to over years ago. Other Issues Many of the studies that have been performed analyzing the potential benefit of medicinal cannabis in treating chronic pain have small sample sizes. Enhancing Healthcare Team Outcomes The treatment of chronic pain requires an interprofessional approach. Review Questions Access free multiple choice questions on this topic. Comment on this article. References 1. Kuehn B. Chronic Pain Prevalence. Hill KP. Opposite effects of deltatetrahydrocannabinol and cannabidiol on human brain function and psychopathology. Kondrad E. Medical marijuana for chronic pain. Ryan J, Sharts-Hopko N. J Neurosci Nurs. Arnold JC. A primer on medicinal cannabis safety and potential adverse effects. Aust J Gen Pract. Crocq MA. History of cannabis and the endocannabinoid system. Dialogues Clin Neurosci. Chronic pain patients' perspectives of medical cannabis. J Pain. Association between county level cannabis dispensary counts and opioid related mortality rates in the United States: panel data study. The role of cannabinoids in pain control: the good, the bad, and the ugly. Minerva Anestesiol. Consensus recommendations on dosing and administration of medical cannabis to treat chronic pain: results of a modified Delphi process. J Cannabis Res. Medicinal Cannabis for Treatment of Chronic Pain. In: StatPearls \[Internet\]. In this Page. Bulk Download. Related information. Recent Activity. Clear Turn Off Turn On. Follow NCBI.

Buying Cannabis At-Taif